William Blair on Biogen (BIIB): 'we see potential to add $1.54 billion in sales' through APLS deal

March 31, 2026 3:28 PM

William Blair analyst Myles R. Minter reiterated an Outperform rating on Biogen (NASDAQ: BIIB)The analyst commented, "There will be debate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

StreetInsider

Log in to your account:

William Blair on Biogen (BIIB): 'we see potential to add $1.54 billion in sales' through APLS deal

Categories